Creation of leaderless FMDV replicon for development of replication defective virus (leaderless FMDV): A strategy towards the development of attenuated vaccine with marker facility by Sarkar, Swaroop et al.
Indian Journal of Biotechnology 
Vol. 20, January 2021, pp 26-34 
Creation of leaderless FMDV replicon for development of replication defective 
virus (leaderless FMDV): A strategy towards the development of attenuated 
vaccine with marker facility 
Swaroop Sarkar1,2, V V S Suryanarayana1, G R Reddy1, H J Dechamma1, S R Madhan Shankar3 
1Indian Veterinary Research Institute, Hebbal, Bangalore- 560024, India 
2Research and Development Centre, Bharathiar University, Coimbatore- 641046, India 
3Dean Academics, Kongunadu arts and science college, Coimbatore, Tamil Nadu- 641046, India 
Received 18 October 2020 ; revised & accepted 15 November 2020 
Leader protease (Lpro) of foot-and-mouth disease virus (FMDV) which is essential for viral replication and pathogenicity 
in host is found in two forms, Lab and Lb with similar activity but, both differing only at amino-termini with separate 
initiation codons, 84 nucleotides apart. After translation of the genomic RNA into single polyprotein, the 
L protease is released autocatalytic from the N terminus and cleaves the p220 subunit of the eukaryotic initiation factor 4F 
complex resulting in the shut off host protein synthesis, an essential step for viral pathogenicity. We exploited this function 
for development of attenuated virus by deleting the gene encoding Lb protease from FMDV Asia 1(63/72) cDNA replicon 
(Joshi et al, 2013) by PCR mutagenesis approach. The deletions and intactness of the frames were confirmed by sequence 
analysis. P1-2A polyprotein gene of FMDV ‘O’ was inserted into the replicon and the full length construct was studied for 
virulence to baby hamster kidney (BHK) 21 cells. Vaccinia expressing T7 polymerase was used for in vitro RNA generation 
and infection. The lower cytopathic effect (cpe) as observed by reduced replication efficiency confirmed the effect of Lb 
deletion when compared with the construct with no deletion.
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Introduction 
The leader proteinase (Lpro) of foot-and-mouth 
disease virus (FMDV) is a papain-like proteinase1 that 
plays an important role in FMDV pathogenesis. The 
inhibitor and site-directed mutagenesis studies have 
confirmed that it belongs to this class of proteinases2-3. 
Lpro is involved in the inhibition of the type I 
interferon (IFN) response during virus infection and 
Lbpro, a shorter form of Lpro, has been reported to have 
deubiquitinating activity4. 
The L gene is present at the 5’ end of the open 
reading frame (ORF) and contains two in-frame 
initiation codons which are 84 nucleotides apart and 
encodes proteins called as Lab and Lb5. All FMDV 
serotypes carry these two initiation codons and are 
detected in in vitro translation and in infected cells6-7 
and the first AUG (at the start of Lab) is not always 
required to initiate replication efficiently8. The L 
protein auto catalytically cleaves itself from the N-
terminus of the elongating polyprotein in trans9, 
exposing the N-terminus of the capsid precursor 
protein P1, permitting its N-terminal myristoylation10.  
L protease leaves the p220 subunit of eukaryotic 
initiation factor 4F (eIF-4F)11-12 that results in the shut 
off	of cap-dependent host mRNA translation13. 
The classical viral vaccines using inactivated 
viruses have the limitations of poor and short duration 
of immune response and hence not successful in some 
cases14, such as human immune deficiency virus or 
herpes simplex virus. Live attenuated virus vaccines 
can overcome these limitations, however naturally 
attenuated viruses have the well-known problem of 
instability15 as the mutation at a limited number of 
sites could easily revert to virulence. Therefore an 
alternative approach to attenuate the virus is by 
genetic modified by creating necessary deletions in 
the genome. Attempts to attenuate FMDV by deletion 
of the poly (C) tract near the 5’ end of the genome17 
have been made with no success. Attenuated 
cardio virus has been produced using classical genetics 
engineering techniques. A genetically modified 
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leader (L) proteinase was developed18. The leaderless 
virus was shown to be attenuated both in tissue 
culture and in suckling mice. However, in order to 
develop polyvalent vaccine, this approach needs to be 
repeated with every serotype. 
Here we report the generation of leaderless FMDV 
replicon as a first step and study its application in 
generating live attenuated FMD vaccines with desired 
serotype. 
Materials and Methods 
Deletion of Lb-Protease Gene from the Replicon 
Full length cDNA clone of FMDV Asia 1 63/72 
(vaccine strain) is available in the laboratory 
(Suryanarayana et al, 2003). A replicon of the same 
was developed by creating restriction sites and 
deleting the capsid coding region, P1-2A and was 
used for Lb protease gene deletion. The sequence 
corresponding to part of 5’UTR and part of 2B 
carrying unique restriction sites (XbaI and BglII) was 
amplified as two fragments which are, 1. Part of UTR 
with unique XbaI site to beginning of VP4 and 2. 
Beginning of VP4 to part of 2B with unique BglII  
site. The primers used for this purpose are shown 
below: 
1 UTR (XbaI) (L): CCA GGT CTA GAG GGG 
TGA CAC CTT 24 mer 
2 UTR-VP4 link(R) : TTG CCG GGC TGG ATT 
GCC CGG CTC CCA TTT TCT CTT GTG TCC 
GTA GAA GA 50 mer 
3 VP4-2B (L): TCT TCT ACG GAC ACA AGA 
GAA AAT GGG AGC CGG GCA ATC CAG 
CCC GGC AA 50 mer 
4 2BR (R) HindIII/BglII: GCA AGC TTG CGA 
GTC GGA GAT CTT CTT CAC 30 mer 
Both the fragments were annealed at the 
complementary region and treated with Klenow for 
primer extension in the presence of dNTPs. The 
primer extended DNA was used as template 
to amplify UTR-2B fragment with deleted 
Lb-protease gene. 
Infectivity Studies on the Transcripts of Full-Length 
Constructs 
Insertion of Green Fluorescent Protein (GFP) Gene into 
Replicon for In Vitro Studies 
In order to confirm the defective replication 
thereby attenuation in vitro we have inserted GFP 
gene in frame in the place of structural protein genes 
(P1-2A). Level of fluorescence in the transfected 
BHK cells indicates the level of attenuation. 
GFP Cloning in L-Deleted Asia 1 63/72 cDNA 
The 2A region of FMDV plays a pivotal role in 
viral replication, therefore, it is essential to include 
2A gene along with the green fluorescent protein 
(GFP) gene. To do this we first cloned P1-2A and a 
part of 2B (2.6 kb) region of Asia 1 63/72 into pBKS+ 
plasmid at EcoRI and XhoI and this was further used 
for cloning GFP sequence.  
The GFP sequence was amplified from a plasmid 
carrying GFP gene (pCGFP) using the primers  




The amplified product (750 bp) was purified from 
agarose gel and inserted into pBKS+ vector carrying 
P1-2A gene of Asia 1 63/72 at EcoRI and NheI site 
thereby replacing P1 region with GFP while retaining 
2A. Finally, the GFP along with 2A region was 
cloned into FMDV genome lacking L region at 
BamH1 site. The full-length cDNA with GFP gene 
was transcribed in vitro using transcription kit. The 
RNA was purified and about 10 µg of each RNA 
transcript was transfected into BHK cells as per 
standard protocol using transfectamine 2000 reagent 
(Invitrogen, USA) 
Generation of Gene Deleted FMDV Chimeric ‘O’ cDNA 
Construct 
Asia 1 replicon with L-deletion was used to generate 
FMDV type ‘O (chimeric ‘O’). The methodology to 
generate full length cDNA construct with P1-2A of 
FMDV ‘O’ R2/75 (Indian vaccine virus) was described 
elsewhere (Joshi et al, 2013). Using this approach P1-2A 
of ‘O’ was introduced into the Lb gene deleted replicons 
at created BamHI site and the un-deleted replicon with 
P1-2A ‘O’ served as a positive control. 
Development of Biosynthetic Viruses with Gene Deleted 
Constructs 
BHK 21 clone 13 cell line was grown in DMEM 
with 10% fetal bovine serum (FBS, HI Media) at 5% 
CO2 tension in 6 well tissue culture dishes to 90% 
confluence. The cells were washed thrice with DMEM 
without serum and the cells were infected with 
recombinant vaccinia virus vTF7-3 (Fuerst et al, 1986) 
expressing T7 DNA dependent RNA polymerase at 
multiplicity of infection (moi) 10 at 37oC for 45 min. 
The cells were washed once, with Opti-MEM 
(Invitrogen, USA) and transfected with the plasmid, 
linearized at the restriction site Not1, downstream of 
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poly (A) tract, using lipofectamine-2000 as per 
manufacturer’s protocol. Briefly, 2 to 4 µg of 
linearised DNA in 250 µl of Opti-MEM was mixed 
with 6 µl of lipofectamine in 250 µl Opti-MEM, 
incubated for 20 min at room temperature and the 
DNA- liposome mixture was layered slowly on the 
mono layer. The cells were incubated at 37oC with 5% 
CO2 tension for 4 hr. Later the transfection mixture 
was replaced with DMEM containing 0.5% FBS and 
further incubated for 48 hrs. The infected cells (with 
vaccinia and FMDV) were harvested by two 
freeze-thaw cycles, treated with 1% (v/v) 
chloroformate 4oC and the supernatant (500 µl) after 
centrifugation at 10,000 g for 10 min was used for 
subsequent passage in to BHK-21 cells in 6-well cell 
culture dish. After the first passage (after 24 hrs) the 
total RNA was extracted from infected cells with 
trizol (Invitrogen) reagent as per the manufacturer’s 
protocol and 1 µg of the total RNA was used for 
subsequent transfection in to BHK-21 cells in 6-well 
cell culture dish. This step helps inner moving 
the vaccinia virus in the infected culture. The cells 
were observed for cytopathic effect (cpe) for 
24 hr post infection (PI). The FMDV in the cell 
supernatant was collected, 500 µl of the supernatant 
was passaged in BHK cells in 25 cm 2 cell culture 
flasks. The virus from each passage was collected and 
stored at -70oC after chloroform treatment as 
described before.  
Characterization of the Biosynthetic Viruses 
The virus was studied for the absence of the 
deleted genes and replication efficiency by RT/PCR 
using specific primers, immunoblot analysis of the 
virus infected cell culture supernatants and by 
infectivity studies in cell culture. 
Results 
 
Generation of Lb deleted FMDV Asia 1 Replicon 
The replicon minus Lb gene was transferred into 
E. coli Top 10 cells. A number of transformants were
seen on ampicillin plate and colonies were screened
by colony PCR using IRES (L) and VP4-UTR link
(R) primers. Since, the VP4-UTR link primer cannot
bind undeleted gene the amplification is expected
only with the deleted full length replicon, but not with
un-deleted one. As seen in the Figure 1, amplification
of 850 bp fragment (lane 2) in the case deleted
construct and around 1.3 kb in the case of undeleted
construct (lane 1) confirms the deletion of the Lb
fragment of around 500 bp between IRES to VP4.
The Lb-deleted replicon pFLA(v)-L (Fig. 2) was used 
for further studies to develop an attenuated virus. 
The sequence was subjected for BLAST search 
(Fig. 3) using NCBI programme for further 
confirmation of the deleted regions. 
Insertion of GFP Gene in PFLA (v)-L 
GFP gene was inserted in to pFLA (v)-L and 
studied for the insertion as described under materials 
and methods. The colonies were initially screened by 
colony PCR. Of the three colonies that were positive 
by colony PCR, plasmids from two were digested 
with BamHI and the fragments analyzed by agarose 
gel electrophoresis. As seen in the Figure 4 there is a 
release of around 1.0 kb fragment after BamHI digestion of 
the plasmids from both the L deleted (lane 1, 2) clones. The 
size of the GFP gene is 716 bp, along with the downstream 
2A and part of 2B the total size of the insert would be 
1.0 kb which is the observed size. GFP insert in both the 
cases is of the same size indicating both the constructs are 
intact as far as GFP-2A-2B insert is concerned. The 
plasmids from the confirmed clones were purified and used 
for replication studies in BHK cells. 
Replication Efficiency of GFP Gene Inserted Replicons with 
Lb Deletions 
RNA transcripts of NotI linearized constructs were 
synthesized in vitro using Thermo Fischer’s high 
yield RNA transcription kit. After DNAse treatment 
to remove template the RNA transcript in each case 
was purified, re-suspended in DEPC treated water and 
studied for biological activity in BHK 21 cells. The 
expression of GFP was in transfected cells was 
monitored 48 hr post transfection (Fig. 5). Though the 
intensity is less the number of cells showing 
fluorescence were higher in the case of undeleted 
Fig. 1 — Analysis of the PCR amplified products from Lb
un-deleted and deleted FMDV replicons, Lane 1 & 2 — amplified 
products from undeleted and deleted constructs respectively.
Lane 3 — 1.0 Kb ladder  
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replicon (Fig. 5B)  than L replicon (Fig. 5D). As  seen 
in the Figure 5, when the transfected cells were 
visualized under visible light (Fig. 5A and C) there was 
a visible difference in the cell morphology. Cells 
transfected with undeleted replication (Fig. 5C) showed 
more rounding and bulging appearance as compared to 
pathogenicity in the case of deleted construct (Fig. 5A) 
indicating the reduced replication efficiency in the case 
of deleted construct. 
Infectivity Studies on Full Length Chimeric ‘O’ cDNA with 
Lb deletion or without 
Insertion of FMDV Serotype ‘O’ (R2/75, Vaccine Strain) P1-
2A into Gene Deleted Replicons 
Polyprotein coding region P1-2A of FMDV ‘O’ 
was released from pBO-P1-2A with BamHI and 
cloned into Lpro gene- deleted full length Asia 1 63/72 
replicon as described under methods. Plasmids from 
transformants were purified and screened for the 
presence of inserted P1-2A by BamHI digestion and 
agarose gel electrophoresis. Since the P1-2A was 
cloned in a created single BamHI site, initially the 
transformants were screened for the presence of insert 
in positive orientation by PCR using reverse 
primer corresponding to 3A and forward primer 
corresponding to VP 4. The PCR positive colonies 
(data not shown) were further studied for the presence 
of ‘O’ P1-2A insert by restriction enzyme digestion. 
As shown in the Figure 6, of the four colonies (lane 1, 
2, 3, 5) screened for the release of 2.8 kb fragment 
one showed the release of the insert of size 2.8 kb 
upon digestion with BamH1 (Fig. 6, lane 5). The 
positive L-deleted full length ‘O’ construct was 
designated as pBFLO∆Lb. 
Infectivity Studies on the Transcripts of Full Length 
Constructs 
In order to achieve in vivo transcription and 
subsequent infection in BHK-21 cells, we have 
studied the infectivity of the plasmid DNA after 
transfection in genetically modified recombinant 
BHK cells expressing T7 RNA polymerase. The 
efficacy of the virus rescue in this case was compared 
with the cells co-infected with the full length DNA 
construct along with the recombinant vaccinia virus 
expressing T7 RNA polymerase. In the case of 
vaccinia system the recombinant vaccinia virus was 
allowed to infect BHK cells prior to transfection with 
the Not I linearized DNAs as described under 
materials and methods. The efficiency of virus rescue 
in the case of cells (clone 2/1) expressing T7 RNA 
polymerase was studied by transfecting with NotI 
linearized DNAs (Fig. 7). More than 80% cpe was 
observed in the case of FLO(-Lb) at First passage 
(B, C). However, the efficiency of virus rescue is 
high with vaccinia system (B) as compared to T7 RNA 
polymerase expressing cell system (C). This may be 
due to the higher level of RNA polymerase production 
in the case of recombinant vaccinia virus system. 
Fig. 2 — Ladder sequences corresponding to IRES to 2B region of the pFLA(v)–L replicon. The nucleotide sequence of 485 bp
corresponding to IRES is with red colour, The nucleotide sequence corresponding to part of undeleted leader (La) of 87 nts is shown with
green, The black coloured sequence corresponds to partial 2B gene. Lb deletion is shown with symbol Δ. Created BamHI site for P1-2A 
insertion and XbaI at the beginning of IRES in the replicon are underlined. 
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Fig. 3 — Sequence alignment of the 786 nucleotides corresponding to IRES-2B (-L) in the replicon with the available
sequence of FMDV - type Asia 1 isolate IND 81-86, complete genome (Sequence ID: gb|DQ989306.1|Length: 8227Number of 
Matches: 3). 
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Characterization of the Viruses Produced 
The lysates from the FLO and FLO∆L infected cell 
monolayers were further studied for Lb protein 
expression by SDS-PAGE and immune blot 
using antiserum raised against E. coli expressed Lb 
protease. The lysate supernatants were collected 48 hr 
post infection and the ammonium sulphate 
precipitated proteins were analyzed by 15% SDS 
PAGE and immuoblot assay for the presence or 
absence of Lb protease in the infected cells. Positive 
colour reaction was observed with antiserum against 
Lb protease in the case of lysates from chimeric ‘O’ 
infected BHK cells but not in the case of ‘O’-Lb 
infected cells (data not shown) indicating there was 
no Lb expression in Lb deleted virus. However, Lb 
deleted virus showed infectivity both in wild BHK 
cells and BHK cells expressing T7 polymerase, but 
the efficiency of replication was lesser than ‘O’ in 
BHK cells. This indicates that the Lb deleted virus is 
less virulent. 
Further, the virus replication in the RNA 
transfected cells were confirmed by the presence of 
virus specific 5’ L-UTR amplification from the cDNA 
prepared with the primer corresponding to 3’ end of 
the viral RNA i.e 3’UTR (R) primer from the RNA 
isolated from transfected cells 48 hr post infection. 
One µg of total RNA was used for amplification 
studies. 
As seen in the Figure 8, (lanes 1 - 3) below all the 
transcripts showed the amplification of around 750 bp 
fragment from all the cDNAs. Intense amplification 
was seen with full length plasmid DNA which was 
Fig. 4 — Release of GFP insert from Lb deleted replicons
pFLA(v)-L (Lane 1, 2) Lane 3: 1 Kb ladder. 
Fig. 5 — A: GFP expression in BHK cells, B: Lb undeleted, C: the transfected cells visualized under visible light and D: Lb deleted and 
GFP inserted replicons as visualized under fluorescence.  
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used as positive control (lane 3). In the case of chimeric 
biosynthetic viruses (lanes 1, 2) there was a marked 
difference in the intensity of the amplified products. It 
was less in the case of FLO∆L indicating the efficiency 
is less which may be due to the absence of Lb protease 
which is needed for virulence. Hence this can be 
evaluated as an attenuated vaccine in animal model. 
Discussion 
Previous strategy to generate attenuated viruses for 
vaccine development is by serially passaging the virus 
in non permissive host systems and selecting the 
mutant viruses that are naturally selected. The 
mutations that occur in natural selection are generally 
of point mutation- type or limited deletions that can 
affect the virus replication to a limited extent but to a 
great extent viral pathogenesis to the host system. 
Such natural mutations are highly prone to reversion 
making the virus to be virulent thereby causing 
disease outbreaks in the vaccinated animal.  
In recent past several issues have come up, 
questioning their safety and therefore some countries 
like USA have stopped using such vaccine. Therefore, 
alternative approaches have been worked out which 
includes use of chimeric viruses where the gene 
encoding for immunogen is inserted into non host 
specific virus and use as vaccines, best examples are 
use of non host specific adenoviruses and some 
poultry viruses for preparation of vaccines against 
animal diseases. However, such approach is not found 
to be successful for the development of potent 
vaccines against some of the diseases where 
immunogen expression alone is not sufficient. Foot 
and mouth disease of cloven footed animals is one of 
such disease concern being aimed for global 
eradication. Natural selection of attenuated FMDV 
through passage in mouse brain was found to be less 
stable as safe vaccine. Presently, chemically 
inactivated FMDV of three anti genically different 
serotypes are used for mass vaccination to control the 
disease. However, this has several issues like poor 
immunogenicity and short duration of immune 
response needing repeated vaccination, risk of escape 
of the pathogen from manufacturing units and 
presence of un-inactivated virus in the vaccine 
causing disease outbreaks in vaccinated animals. 
Hence, global eradication of FMD became a 
challenging task, resulting in constant search for an 
alternative vaccine development. One of the sure shot 
method is to develop live attenuated FMDVs of all the 
serotypes with stable mutation/s and use for mass 
vaccination. This may be possible only by making 
known non-immunogenic gene deletion in the 
laboratory and use as attenuated vaccine. The gene 
deleted viruses can be used as marker vaccine as the 
detection of antibodies against deleted gene product 
will help to differentiate the vaccinated animals from 
the infected.  
Fig. 7 — Infectivity of the transcripts of pBFLO and pBFLO∆Lb to BHK21 cells. 
Fig. 6 — BamHI digested pBFLO∆Lb with and without P1-2A insert. 
Lane 1, 2, 3: construct without insert Lane 4: 1 kb ladder Lane 5:
with P1-2A insert 
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Numerous studies have been conducted with 
genetically modified serotype A FMDVs lacking 
L protease which was shown to be infectious but grow 
more slowly in cell culture and is attenuated in both 
cattle and swine (Brown et al, 1996). Lb is considered 
to be the biologically functional protein following 
initiation of which results in production of live virus 
while the deletion of first AUG codon has no effect 
on viral replication. A serotype A12 virus that lacked 
the L-coding region (leaderless) was constructed. This 
virus replicated in BHK-21 cells but did not cause 
disease in cattle or swine (Piccone et al, 1995). It 
greatly reduced pathogenicity in susceptible animals, 
leaderless virus was examined as a live attenuated 
vaccine candidate, induced neutralizing antibody 
response in both the species. Taken together, our 
results and those of Brown and Piccone et al. suggest 
that the deletion of LbPro approach can be used for the 
production of replication defective FMDV and 
subsequent studies on their use as attenuated vaccines.  
The L-protease gene responsible for pathogenesis 
was selected for deletion studies and deletion was 
successfully carried out. Since, this approach is to be 
followed for all vaccine strains to be used as 
polyvalent vaccine, we have made FMDV replicon 
with Asia 1 serotype and used the replicon for 
deletion . This would help development of polyvalent 
live attenuated vaccine. There was reduction in 
virulence in the case of Lb deleted RNA as seen 
in vitro studies using BHK cell monolayers indicating 
the Lb deleted virus may be used as an attenuated 
virus vaccine.  
Towards the development of companion tests for 
marker vaccines, and for evaluating the gene deleted 
viruses in vitro for replication efficiency, we have 
cloned the deleted genes in expression vector, 
expressed the proteins in E. coli, raised antisera 
(Sarkar et al, 2017) in experimental animals and used. 
The viruses need to be further evaluated for 
attenuation and immunogenicity in homologous host. 
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